iAB Financial Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$386K Sell
12,110
-2,567
-17% -$81K 0.19% 104
2017
Q1
$476K Buy
14,677
+166
+1% +$5.23K 0.24% 86
2016
Q4
$447K Buy
14,511
+4,057
+39% +$124K 0.25% 80
2016
Q3
$336K Buy
10,454
+3,205
+44% +$107K 0.2% 92
2016
Q2
$242K Buy
+7,249
New +$231K 0.15% 105

Other funds holding PFE

iAB Financial Bank's PFE Position: Q2 2017 in Review

iAB Financial Bank reduced its Pfizer (PFE) stake by 17% in Q2 2017, selling an estimated $81K and leaving 12,110 shares worth $386K. The position accounts for 0.19% of the portfolio, ranked #104.

iAB Financial Bank first reported a position in PFE in Q2 2016 and has held it in 5 quarters since. The position peaked at $476K in Q1 2017. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • iAB Financial Bank held 12,110 shares of Pfizer worth $386K as of Q2 2017.
  • iAB Financial Bank sold 2,567 Pfizer shares in Q2 2017, an estimated $81K.
  • Pfizer made up 0.19% of iAB Financial Bank's portfolio in Q2 2017, its #104 holding.
  • iAB Financial Bank first reported a position in Pfizer in Q2 2016 and has held it in 5 quarters since.
  • iAB Financial Bank's Pfizer position peaked at $476K in Q1 2017.
  • 2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on iAB Financial Bank's 13F filing for Q2 2017, filed 4 Aug 2017.